Synthesis and Antiproliferative Evaluation of Certain Indeno[1,2-c]quinoline Derivatives. Part 2

被引:80
作者
Tseng, Chih-Hua [2 ]
Tzeng, Cherng-Chyi [2 ]
Yang, Chiao-Li [2 ]
Lu, Pei-Jung [3 ]
Chen, Hui-Ling [3 ]
Li, Hao-Yi [1 ]
Chuang, You-Chung [1 ]
Yang, Chia-Ning [1 ]
Chen, Yeh-Long [2 ]
机构
[1] Natl Univ Kaohsiung, Inst Biotechnol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Dept Med & Appl Chem, Coll Life Sci, Kaohsiung 807, Taiwan
[3] Natl Cheng Kung Univ, Inst Clin Med, Sch Med, Tainan 70428, Taiwan
关键词
TOPOISOMERASE-I INHIBITORS; POTENTIAL ANTITUMOR AGENTS; BIOLOGICAL EVALUATION; ANTICANCER EVALUATION; CYTOTOXIC EVALUATION; DUAL INHIBITOR; CAMPTOTHECIN; MECHANISM; ANALOGS; TAS-103;
D O I
10.1021/jm1005447
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Certain indeno[1,2-c]quinoline derivatives were synthesized and evaluated for their antiproliferation, DNA binding affinity, and topoisomerases (topo 1 and topo II) inhibitory activities. The preliminary results are the following: (1) substituent of the aminoalkoxyimino side chain at C11 is important for antiproliferative activities in which the terminal amine preferred to be a tertiary or the cyclic five-membered pyrrolidino ring; (2) among the indeno[1,2-c]quinoline derivatives evaluated, (E)-6-hydroxy-9-methoxy-1 1/1-indeno[1,26quinolin-1 I-one 0-2-(pyrrolidin-I-yDethyl oxime (8c) was found to be one of the most cytotoxic agents with a GI50 value of 0.84, 0.89, and 0.79/iM against SAS, A549, and BT483, respectively, which is more active than camptothecin; (3) substituent at C6 is crucial for the selective cytotoxicity in which the OH group is the most preferred while hydrogen or piperazine exhibited cytotoxicity on both cancer cells and Detroit551; (4) a positive correlation of antiproliferative activity, DNA binding affinity, and topo 1 and topo II inhibitory activities has been observed for indeno[1,2-c]quinoline derivatives; (5) compound 8c induced DNA fragmentation may through caspase-3 activation, phosphorylation of the histone protein H2AX at Ser139 (y-1-12AX), and PA RP cleavage; (6) compound 8c demonstrated significant tumor regression in the human breast xenograft model; (7) indeno[I,2-c]quinoline derivatives are a new class of-molecules that have the potential to be developed as dual topo 1 and topo 11 inhibitory agents.
引用
收藏
页码:6164 / 6179
页数:16
相关论文
共 70 条
  • [1] Targeting p70S6K Prevented Lung Metastasis in a Breast Cancer Xenograft Model
    Akar, Ugur
    Ozpolat, Bulent
    Mehta, Kapil
    Lopez-Berestein, Gabriel
    Zhang, Dongwei
    Ueno, Naoto T.
    Hortobagyi, Gabriel N.
    Arun, Banu
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1180 - 1187
  • [2] ALSO S, 2005, J OCCUP HEALTH, V47, P249
  • [3] Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives
    AlvarezIbarra, C
    FernandezGranda, R
    Quiroga, ML
    Carbonell, A
    Cardenas, F
    Giralt, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (05) : 668 - 676
  • [4] Antony S, 2003, CANCER RES, V63, P7428
  • [5] In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerases I and II
    Aoyagi, Y
    Kobunai, T
    Utsugi, T
    Oh-hara, T
    Yamada, Y
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (05): : 578 - 587
  • [6] POTENTIAL ANTITUMOR AGENTS .12. 9-ANILINOACRIDINES
    ATWELL, GJ
    CAIN, BF
    SEELYE, RN
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (06) : 611 - &
  • [7] POTENTIAL ANTITUMOR AGENTS .47. 3'-METHYLAMINO ANALOGS OF AMSACRINE WITH INVIVO SOLID TUMOR-ACTIVITY
    ATWELL, GJ
    BAGULEY, BC
    FINLAY, GJ
    REWCASTLE, GW
    DENNY, WA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (09) : 1769 - 1776
  • [8] THE STRUCTURAL BASIS OF CAMPTOTHECIN INTERACTIONS WITH HUMAN SERUM-ALBUMIN - IMPACT ON DRUG STABILITY
    BURKE, TG
    MI, ZH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (01) : 40 - 46
  • [9] 17β-O-aminoalkyloximes of 5β-androstane-3β,14β-diol with digitalis-like activity:: Synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na+,K+-ATPase receptor
    Cerri, A
    Almirante, N
    Barassi, P
    Benicchio, A
    Fedrizzi, G
    Ferrari, P
    Micheletti, R
    Quadri, L
    Ragg, E
    Rossi, R
    Santagostino, M
    Schiavone, A
    Serra, F
    Zappavigna, MP
    Melloni, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (12) : 2332 - 2349
  • [10] Chen I-Li, 2003, Chinese Pharmaceutical Journal (Taipei), V55, P49